Principal Financial Group’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.61M | Sell |
|
|||||
|
2025
Q1 | $8.67M | Sell |
|
|||||
|
2024
Q4 | $10.9M | Sell |
|
|||||
|
2024
Q3 | $11.9M | Buy |
|
|||||
|
2024
Q2 | $12.1M | Sell |
|
|||||
|
2024
Q1 | $46.8M | Buy |
|
|||||
|
2023
Q4 | $36.1M | Buy |
|
|||||
|
2023
Q3 | $22.9M | Sell |
|
|||||
|
2023
Q2 | $24.9M | Sell |
|
|||||
|
2023
Q1 | $29.8M | Buy |
|
|||||
|
2022
Q4 | $13.9M | Sell |
|
|||||
|
2022
Q3 | $12.8M | Sell |
|
|||||
|
2022
Q2 | $14.5M | Buy |
|
|||||
|
2022
Q1 | $18M | Sell |
|
|||||
|
2021
Q4 | $24.7M | Sell |
|
|||||
|
2021
Q3 | $27.5M | Buy |
|
|||||
|
2021
Q2 | $24M | Sell |
|
|||||
|
2021
Q1 | $50.4M | Buy |
|
|||||
|
2020
Q4 | $37.5M | Buy |
|
|||||
|
2020
Q3 | $34M | Sell |
|
|||||
|
2020
Q2 | $27M | Buy |
|
|||||
|
2020
Q1 | $19M | Sell |
|
|||||
|
2019
Q4 | $32.6M | Buy |
|
|||||
|
2019
Q3 | $28.3M | Sell |
|
|||||
|
2019
Q2 | $30.9M | Buy |
|
|||||
|
2019
Q1 | $31.2M | Buy |
|
|||||
|
2018
Q4 | $24M | Sell |
|
|||||
|
2018
Q3 | $29.1M | Buy |
|
|||||
|
2018
Q2 | $23.9M | Buy |
|
|||||
|
2018
Q1 | $22.2M | Buy |
|
|||||
|
2017
Q4 | $22.2M | Sell |
|
|||||
|
2017
Q3 | $22M | Buy |
|
|||||
|
2017
Q2 | $20.1M | Buy |
|
|||||
|
2017
Q1 | $17.1M | Sell |
|
|||||
|
2016
Q4 | $14.5M | Sell |
|
|||||
|
2016
Q3 | $40M | Sell |
|
|||||
|
2016
Q2 | $41M | Buy |
|
|||||
|
2016
Q1 | $16.9M | Buy |
|
|||||
|
2015
Q4 | $12.1M | Buy |
|
|||||
|
2015
Q3 | $9.3M | Buy |
|
|||||
|
2015
Q2 | $9.97M | Buy |
|
|||||
|
2015
Q1 | $10.7M | Buy |
|
|||||
|
2014
Q4 | $8.3M | Sell |
|
|||||
|
2014
Q3 | $11.7M | Sell |
|
|||||
|
2014
Q2 | $16.3M | Buy |
|
|||||
|
2014
Q1 | $18.1M | Buy |
|
|||||
|
2013
Q4 | $6.47M | Sell |
|
|||||
|
2013
Q3 | $5.78M | Buy |
|
|||||
|
2013
Q2 | $5.12M | Buy |
|